Launched at Davos in 2016, Innovation for Uptake, Scale and Equity in Immunisation (INFUSE) helps improve vaccine delivery systems by connecting high-impact, proven innovations with the countries that need them most.
It then “infuses” them with capital and expertise to help take them to scale.
Global immunisation coverage has stalled at around 80% for several years. It takes new thinking and technology to modernise delivery systems and ensure life-saving vaccines reach all children.
Drawing on the comparative advantages of businesses, governments and other partners, Gavi created INFUSE to help countries accelerate the introduction of cutting edge technology.
Each year the most promising innovations are selected as INFUSE Pacesetters to receive Gavi and partner support. By connecting local entrepreneurs to Alliance partners, INFUSE creates an innovation ecosystem that brings to bear new ideas and technologies that can revolutionise immunisation.
INFUSE also helps advance gender equality by providing a platform that encourages female entrepreneurship. Some INFUSE Pacesetters are women-led businesses, which are proven to not only drive economic growth, but also act as catalysts for social change.
Vaccine delivery systems in developing countries often rely on technologies and approaches that haven't been updated in years or sometimes decades. This can slow or even stop the delivery of life-saving vaccines.
There are many potential solutions but they lack the right market conditions for scale-up. Businesses offering new technology frequently struggle to secure the necessary funding, while governments can lack the expertise required to select appropriate, cost-effective solutions.
INFUSE aims to address this challenge by connecting tried and tested innovations to the countries that need them most.
Faster with wings: Ghana’s immunisation rates soar in Zipline-served districts
Drone delivery of vaccines has helped immunisation programmes in remote parts of Ghana’s Western North region bounce back faster than average from the pandemic’s impact, new research says. VaccinesWork visited the Zipline regional hub to find out…
The US$ 500 million challenge: Gavi launches INFUSE 2.0 to scale up innovations in immunisation
INFUSE is an innovation scaling hub that matches investors with innovators and entrepreneurs to help scale up new ways to improve vaccination coverage in lower-income countries
5 questions with Parsyl’s Souleymane Sawadogo
Souleymane Sawadogo, Vice President of Global Health at Parsyl, tells us how innovation and data are revolutionising vaccine supply chains.
